Kane Biotech (KNE) to Release Earnings on Thursday

Kane Biotech (CVE:KNE) is scheduled to post its quarterly earnings results after the market closes on Thursday, March 22nd.

Shares of KNE stock opened at C$0.07 on Wednesday. The firm has a market cap of $6.01, a PE ratio of -1.40 and a beta of 0.59. Kane Biotech has a 1 year low of C$0.07 and a 1 year high of C$0.18.

ILLEGAL ACTIVITY NOTICE: “Kane Biotech (KNE) to Release Earnings on Thursday” was originally reported by Stock Observer and is the property of of Stock Observer. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thestockobserver.com/2018/03/21/kane-biotech-kne-to-release-earnings-on-thursday.html.

Kane Biotech Company Profile

Kane Biotech Inc is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company’s technologies include DispersinB, AloSera, Aledex, Strix NB, bluestem and KBI Disinfectant. It is focused on the companion animal market with Strix NB brand for the veterinary segment and bluestem brand for the pet over the counter (OTC) retail market.

Earnings History for Kane Biotech (CVE:KNE)

Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply